NIA PILOT RESEARCH GRANT PROGRAM
Release Date: December 20, 2000 (This announcement has been superceded by
PAR-02-049)
PA NUMBER: PA-01-037
National Institute on Aging
Application Receipt Dates: March 20, 2001, July 17, 2001, November 16, 2001
THIS PA USES MODULAR GRANT AND JUST-IN-TIME APPLICATION PROCEDURES. IT
INCLUDES DETAILED MODIFICATIONS TO STANDARD APPLICATION INSTRUCTIONS
THAT MUST BE USED WHEN PREPARING APPLICATIONS IN RESPONSE TO THIS PA.
PURPOSE
The National Institute on Aging (NIA) is seeking small grant (R03)
applications in specific areas to: (1) stimulate and facilitate the
entry of promising new investigators into aging research, and (2)
encourage established investigators to enter new targeted, high
priority areas in this research field. This Small Grant (R03) Program
provides support for pilot research that is likely to lead to a
subsequent individual research project grant (R01) that is focused on
aging and/or a significant advancement of aging research.
HEALTHY PEOPLE 2010
The Public Health Service (PHS) is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2010," a
PHS led national activity for setting priority areas. This Program
Announcement (PA), the NIA PILOT RESEARCH GRANT PROGRAM, is related to
one or more of the priority areas. Potential applicants may obtain a
copy of "Healthy People 2010" at http://www.health.gov/healthypeople/.
ELIGIBILITY REQUIREMENTS
Applications may be submitted by domestic for-profit and non-profit
organizations, public and private, such as universities, colleges,
hospitals, laboratories, units of State and local governments, and
eligible agencies of the Federal government. Racial/ethnic minority
individuals, women, and persons with disabilities are encouraged to
apply as principal investigators. Foreign organizations and
institutions are not eligible. Participation in the program by
investigators at minority institutions is strongly encouraged.
New or established investigators are eligible to apply for this award.
(1) Investigators are considered new when they are neither current nor
former principal investigators on NIH research project (R01), FIRST
Awards (R29), sub-projects of program project (P01) or center grants
(P50), and the equivalent. If the applicant is in the final stages of
training it is permissible to apply for an R03 but no award will be
made to individuals who are still in training or fellowship status at
the time of award (see reference to Biographical sketch under
Application Procedures). (2) For an established investigator to be
eligible the individual must propose research that is unrelated to any
federally-funded research project in which the investigator
participates.
MECHANISM OF SUPPORT
Applicants may request either $25,000 or $50,000 in direct costs for
one year through the small grant (R03) mechanism. These awards are not
renewable. Before completion of the R03, investigators are encouraged
to seek continuing support for research through a research project
grant (R01). Specific application instructions have been modified to
reflect "MODULAR GRANT" and "JUST-IN-TIME" streamlining efforts being
examined by NIH. Complete and detailed instructions and information on
Modular Grant applications can be found at:
http://grants.nih.gov/grants/funding/modular/modular.htm.
Replacement of the Principal Investigator on this award is not
permitted. Revisions of applications previously reviewed under this
initiative but unfunded are not permitted. A new application must be
substantially different from one previously reviewed and have a
different title in order to be accepted for review. It must focus on
one of the topics in the announcement that is active when the new
application is submitted. All applications will be reviewed as new
applications.
RESEARCH OBJECTIVES
Investigators may apply for a small grant in one of the following
areas. Applications for support in other areas will be returned to the
proposed Principal Investigator without review. Investigators should
follow the instructions described under APPLICATION PROCEDURES to
identify the topic on which the application is focused.
1. HIV/AIDS and Aging: Behavioral, social, clinical, neuroscientific,
and/or biological research on older people infected by, and affected
by, HIV/AIDS. Also social, economic, and health consequences of
HIV/AIDS for older persons as parents and relatives of HIV infected
adults, in both developed and developing countries. Prevention sciences
research is encouraged, and both basic and applied research are
welcomed.
2. Racial/Ethnic Differences and Health Disparities: (a) Research
leading to identification of underlying mechanisms, including cellular
and molecular mechanisms, linked to racial/ethnic differences in late
life function or disease e.g. cognition, Alzheimer"s disease,
cardiovascular disease, cancer, infectious diseases, and diabetes. (b)
Research to disentangle the effects of socio-economic status, social
and environmental factors, health behaviors, and race and ethnicity on
health, and (c) Research to develop and improve instruments and
methods, including standardization across population groups, to measure
disorders, disease and disability in minority groups that will lead to
an understanding of the causes of these conditions. NIA"s strategic
plan for addressing health disparities is available from:
http://www.nia.nih.gov/AboutNIA/StrategicPlan/
3. Cardiovascular and Cerebrovascular aging: Behavioral, social,
cellular, and molecular studies of cardiovascular and cerebrovascular
aging. N.B. Applications for clinical studies, exclusively on the
aging cardiovascular system, will not be accepted in response to this
announcement.
4. Stems Cells, Tissue Repair, and Cell Replacement in Aging: Studies
on the biology of stem cells as a function of aging and disease,
genetic and
environmental effects on tissue stem cells, stem cell plasticity,
development of cell markers and imaging techniques to identify and
monitor stem cells in vivo, and
transplantation of stem cells to effect tissue repair. NIH has
published policy guidelines for research using human pluripotent stem
cells and has published procedures to be used in applying for NIH
research funding for this activity. See:
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-050.html and
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-003.html
5. Neural Modeling: Studies to develop computational neural-network
models of neural changes with age that impact behavioral outcomes of
memory, learning, sensory function, and motor function as well as
plasticity.
6. Sensory and Motor Processing: Mechanisms underlying age-related
changes in sensory and motor processing in the central nervous system.
7. Cognition in Context: Studies to understand how differences in
contexts produce systematic variation in cognitive functioning and
performance that are often attributed to sociocultural categories
(e.g., social class, occupation, ethnicity, educational attainment).
Of particular interest is what happens in the contexts of school,
workplace, or social networks to shape the mind and brain, bringing
about systematic intergroup differences in cognition that endure
through the life span.
8. Alzheimer"s Disease Drug Discovery: Studies for preclinical
research in the discovery, design, development and testing of novel
compounds aimed at immunological and other approaches to delaying
decline in cognitive function, and to preventing, slowing the
progression of, or delaying the onset of Alzheimer’s disease.
9. Extracellular Matrix and Cytoskeleton: Studies on age-related
changes in the structure, content, or function of the extracellular
matrix and cytoskeleton, including regulation of cell signaling
cascades, intracellular transport mechanisms, cell motility and
morphology, and cell death.
10. Functional Senescence: Genetic, cellular and biochemical mechanisms
underlying age-related changes in tissues or organs leading to
dysfunction.
11. Psychoneuroimmunology: Studies of how neural and neuroendocrine
mechanisms interact with immune pathways to modulate the aging immune
system response to psychological and pathological challenges, and
studies to understand the mechanisms underlying "placebo" effects with
age.
12. Vaccine Development: Preliminary basic and clinical studies, and
therapeutic trials of vaccines for use in elderly populations.
Vaccines may be prophylactic or therapeutic in nature. These may
include studies of methods to enhance the immune response in older
persons including alternative administration schedules with existing
vaccines, the use of adjuvants, and/or new vaccines.
13. Health-related Consequences of Female Reproductive Aging: Basic
molecular and cellular research to elucidate underlying neuroendocrine,
endocrine and physiologic mechanisms of the female reproductive aging
process, especially 1) changes across the hypothalamic-pituitary-
ovarian axis leading to menopause in women, 2) hormonal and other
changes in the menopausal process associated with increased risk for
peri- and postmenopausal health problems and conditions, and 3) age-
related changes in the biology of hormone action and metabolism.
14. Biology of Age-related Prostate Growth: Basic molecular and
cellular research to explore underlying mechanisms responsible for
prostate growth in men leading to benign prostatic hyperplasia and
prostate cancer.
15. Cancer in the elderly: Studies in persons aged 70 years and older
regarding incidence, survival, and clinical impact in cancers of the
breast, prostate, colorectal, lung, ovarian, and pancreas are
encouraged. Research topics include tumor-related tissue studies,
autopsy investigations, characterization of cancer as it interfaces
with pre-existing health conditions (i.e., comorbidity), overcoming the
practical problems of acquiring data on this age segment of cancer
patients, and quality of survival. Studies with a focus on home and/or
nursing home settings are appropriate. Patterns of care and treatment,
development of clinical evaluation tools specific for the elderly
(e.g., prognostic indicators, geriatric assessment) that can be used by
physicians to determine the patients overall physical and physiologic
health status are also included in this solicitation.
16. Metabolic Regulation: Studies that explore whether intermediary
metabolism changes with advancing age and/or caloric restriction, and
whether there is a relationship between age-related and caloric
restriction-related changes in metabolism. N.B. Applications for
clinical studies in this area will not be accepted in response to this
announcement.
17. Basic Underlying Mechanisms of Musculoskeletal Aging (muscle, bone,
cartilage, neuromuscular junction, peripheral nerve, and motorneuron):
Applications for clinical studies on the aging musculoskeletal system
will be considered non-responsive to this research bullet.
Investigators interested in submitting exploratory/pilot clinical
studies of the aging musculoskeletal system are encouraged to contact
the Geriatrics Program (E-mail: Gpquery@exmur.nia.nih.gov) to
explore other options.
18. Animal Models of Aging: Development of new and informative animal
models for aging research, including genetically defined and or
genetically altered animals.
19. Tools for Research on the Genetics of Aging: Development of tools
such as cDNA full length libraries, single nucleotide polymorphism
(SNP) analysis, and conditional gene expression systems for studying
the genetic basis of aging. High priority will be given to proposals to
demonstrate proof of principle using high throughput technology, e.g.,
microarrays, to obtain data on age-related changes in gene expression
or DNA sequence in addressing questions of gerontological significance.
20. Genetic Epidemiology: Studies to understand the genetic and
environmental basis of complex traits associated with behavioral and
functional aging. Such studies may include but are not limited to: the
application of new analytic strategies to study complex traits or rates
of change, approaches to identify and investigate QTL effects, and
preliminary studies exploring how behaviors or environmental risk
factors, such as stress, affect gene expression. Research into the
psychosocial effects, including the within-family intergenerational
impact, of genetic testing and genetic screening is also encouraged.
Pilot studies for linkage of two or more data sets to facilitate larger
sampling frames by combining familial, health, and psychosocial
information are also of interest.
21. Pilot Data Collection in Population Aging: Feasibility studies
and/or new pilot data collection leading to large-scale, new, or
enhanced studies on retirement, health disparities, trends in
disability, transitions across long-term care settings, biodemography,
and early determinants of late-life health.
22. Improved Measures and Methodologies: Improved measures are
especially needed of adaptation and well-being over the course of
chronic diseases, and following major life events and transitions,
including methods that reconcile objective and subjective measures of
well-being. Summary measures of cumulative social, psychological and
cultural advantage or adversity, and experienced discrimination, are
needed. Cross-national studies to harmonize and validate measures are
encouraged. Innovative methods are needed to meld laboratory,
clinical or ethnographic approaches with large-scale population
studies, including the use of experience-based sampling and the
addition of bio-indicators to social science surveys. New
methodologies to assess progress in the social and behavioral sciences
of aging (e.g., creation of new areas, dissemination to other areas of
science, and the impact of research on public policy and well-being)
are encouraged.
23. Personality, Experimental Social Psychology, and Health
Interventions: Applications are solicited for genetic determinants of
personality traits, personality and social processes, and the role of
personality in health outcomes. Pilot studies are especially needed
that experiment with integrating interventions at the physiological,
psychological, social structural and economic levels. Pilot tests are
needed of innovative multi-level social and behavioral interventions to
enhance social, psychological and economic well-being, as well as
specific lifestyle, self-management and caregiving behaviors. Studies
examining personality and other individual differences that mediate the
effectiveness of behavioral interventions are also encouraged.
Preliminary studies describing the impact of social relationships on
cognitive decline, exploring mediating pathways (including biological),
and suggesting possible new interventions are encouraged.
24. Work, Older Workers, and Organizations: Research is encouraged on
the demographic, economic, social, psychological, and human factors
aspects of older workers in the workplace, with special attention to
the impact of the wide variety of workplace environments and
experiences on older worker health and cognition. Studies of employees
of nursing homes and other long-term care settings are particularly
encouraged, as well as studies of the impact of employee
characteristics (including stereotypes of aging) on patients. Also
encouraged are studies of minorities in supervisory positions (e.g. in
the military or the US civil service) to test whether or not the
health/SES gradient found in the U.K. Whitehall Study holds in the US
and whether or not supervisory roles mitigate against the impact of
negative risk factors on health.
The National Institute on Aging will modify the selected topic areas
annually by reissuing the program announcement. Information on other
initiatives supported by NIA may be found at the following internet
address: http://www.nia.nih.gov/.
INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of the NIH that women and members of minority groups
and their sub-populations must be included in all NIH-supported
biomedical and behavioral research projects involving human subjects,
unless a clear and compelling rationale and justification are provided
indicating that inclusion is inappropriate with respect to the health
of the subjects or the purpose of the research. This policy results
from the NIH Revitalization Act of 1993 (Section 492B of Public Law
103-43).
All investigators proposing research involving human subjects should
read the UPDATED "NIH Guidelines for Inclusion of Women and Minorities
as Subjects in Clinical Research," published in the NIH Guide for
Grants and Contracts on August 2, 2000
(http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-048.html), a
complete copy of the updated Guidelines are available at
http://grants.nih.gov/grants/funding/women_min/guidelines_update.htm:
The revisions relate to NIH defined Phase III clinical trials and
require: a) all applications or proposals and/or protocols to provide a
description of plans to conduct analyses, as appropriate, to address
differences by sex/gender and/or racial/ethnic groups, including
subgroups if applicable, and b) all investigators to report accrual,
and to conduct and report analyses, as appropriate, by sex/gender
and/or racial/ethnic group differences.
URLS IN NIH GRANT APPLICATIONS OR APPENDICES
All applications and proposals for NIH funding must be self-contained
within specified page limitations. Unless otherwise specified in an
NIH solicitation, internet addresses (URLs) should not be used to
provide information necessary to the review because reviewers are under
no obligation to view the Internet sites. Reviewers are cautioned that
their anonymity may be compromised when they directly access an
Internet site.
APPLICATION PROCEDURES
Applications are to be submitted on the grant application form PHS 398
(rev. 4/98) and prepared according to the directions in the application
packet, with the exceptions noted below. Application kits are
available at most institutional offices of sponsored research and may
be obtained from the Division of Extramural Outreach and Information
Resources, National Institutes of Health, 6701 Rockledge Drive, MSC
7910, Bethesda, MD 20892-7910, telephone (301) 710-0267, FAX (301) 480-
0525, Email: grantsinfo@nih.gov. Applications are also available on the
internet at http://grants.nih.gov/grants/funding/phs398/phs398.html
On the face page of the application: Item 2 Type "NIA: PILOT RESEARCH
GRANT PROGRAM" and the number of the program announcement. Check the
"YES" box.
Abstract: The first line of the abstract must list the number and title
of the particular research topic (see RESEARCH OBJECTIVES) being
responded to.
Biographical sketch (also see below under modular procedures):
Applicants who remain in training or in fellowship status at the time
of application should list in their biographical sketch the position
they will occupy at the time of award with the expected start date in
that position. If the position is contingent on receipt of the award
then it should be described as "contingent on award".
Research plan: Do not exceed a total of ten pages for the following
parts (a-d): Specific Aims, Background and Significance, Progress
Report/Preliminary Studies, and Experimental Design and Methods.
Tables and figures are included in the ten page limitation.
Applications that exceed the page limitation or PHS requirements for
type size and margins (Refer to PHS 398 application for details) will
be returned to the investigator. The ten page limitation does not
include parts e through i. (Human Subjects, Vertebrate Animals,
Literature Cited, Consortium Arrangements, Consultants).
Appendix: The only items that may be included in an appendix are
original glossy photographs or color images of gels, micrographs, etc.,
provided that a photocopy (that may be reduced in size) is also
included within the 10 page limit of items a-d in the research plan. No
photographs or color images may be included in the appendix that are
not also represented in the Research Plan. Do not include publications
or preprints.
Materials submitted after the receipt date. No additional materials
pertaining to a particular application will be accepted after the
receipt date for which the application is submitted except for
certifications of Institutional Review Board (IRB) or Institutional
Animal Care and Use Committee (IACUC) approval. As specified in the PHS
398 form, certifications of IACUC approval must be received within 60
days after the receipt date for which the application is submitted. IRB
approval is no longer required prior to review. Institutions should
proceed with IRB review of those applications identified as in the
fundable range following review. See
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-031.html
The NIA pilot grant program will follow modular procedures (See
http://grants.nih.gov/grants/funding/modular/modular.htm) for
application and award. The modular grant concept establishes specific
modules in which direct costs may be requested as well as a maximum
level for requested budgets. Only limited budgetary information is
required under this approach. The just-in-time concept allows
applicants to submit certain information only when there is a
possibility for an award. It is anticipated that these changes will
reduce the administrative burden for the applicants, reviewers and
Institute staff. The research grant application form PHS 398 (rev.
4/98) is to be used in applying for these grants, with the
modifications noted below.
MODULAR BUDGET INSTRUCTIONS
Applications in response to this announcement should request either
$25,000 in total direct costs or $50,000 in total direct costs. The
total direct costs must be requested in accordance with the program
guidelines and the modifications made to the standard PHS 398
application instructions described below:
PHS 398
o FACE PAGE: Items 7a and 7b should be completed, indicating Direct
Costs (either $25,000 or $50,000) and Total Costs [Modular Total Direct
plus
Facilities and Administrative (F&A) costs] for the initial budget
period. As these are one year applications items 8a and 8b should show
the same amounts
as items 7a and 7b.
o DETAILED BUDGET FOR THE INITIAL BUDGET PERIOD - Do not complete Form
Page 4 of the PHS 398. It is not required and will not be accepted
with the application.
o BUDGET FOR THE ENTIRE PROPOSED PERIOD OF SUPPORT - Do not complete
the categorical budget table on Form Page 5 of the PHS 398. It is not
required and will not be accepted with the application.
o NARRATIVE BUDGET JUSTIFICATION - Prepare a Modular Grant Budget
Narrative page. (See
http://grants.nih.gov/grants/funding/modular/modular.htm for sample
pages.) At the top of the page, enter the total direct costs requested
for the award. This is not a Form page.
o Under Personnel, list all project personnel, including their names,
percent of effort, and roles on the project. No individual salary
information should be provided. However, the applicant should use the
NIH appropriation language salary cap and the NIH policy for graduate
student compensation in developing the budget request.
For Consortium/Contractual costs, provide an estimate of total costs
(direct plus facilities and administrative) rounded to the nearest
$1,000. List the individuals/ organizations with whom consortium or
contractual arrangements have been made, the percent effort of all
personnel, and the role on the project. Indicate whether the
collaborating institution is foreign or domestic. The total cost for a
consortium/contractual arrangement is included in the overall requested
modular direct cost amount. Include the Letter of Intent to establish a
consortium.
o BIOGRAPHICAL SKETCH - The Biographical Sketch provides information
used by reviewers in the assessment of each individual"s qualifications
for a specific role in the proposed project, as well as to evaluate the
overall qualifications of the research team. A biographical sketch is
required for all key personnel, following the instructions below. No
more than three pages may be used for each person. A sample
biographical sketch may be viewed at:
http://grants.nih.gov/grants/funding/modular/modular.htm.
- Complete the educational block at the top of the form page, - List
position(s) and any honors, - Provide information, including overall
goals and responsibilities, on research projects ongoing or completed
during the last three years, - List selected peer-reviewed
publications, with full citations.
o CHECKLIST - This page should be completed and submitted with the
application. If the F&A rate agreement has been established, indicate
the type of agreement and the date. All appropriate exclusions must be
applied in the calculation of the F&A costs for the initial budget
period and all future budget years.
o The applicant should provide the name and phone number of the
individual to contact concerning fiscal and administrative issues if
additional information is necessary following the initial review.
Submit a signed, original of the application, and three exact
photocopies, including the checklist, in one package to:
CENTER FOR SCIENTIFIC REVIEW
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC-7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)
In addition, to prepare for review of the application, submit two
additional exact photocopies of the application directly to:
Dr. Mary Nekola
Scientific Review Office
National Institute on Aging
7201 Wisconsin Avenue, Suite 2C212, MSC 9205
Bethesda, MD 20892-9205
It is important that applicants submit two additional copies to the
Scientific Review Office as requested. Amended applications will not
be accepted.
The submission, review, and award schedule for the Pilot Research Grant
Program for 2001 is:
Application Receipt Dates: 03/20/2001 07/17/2001 11/16/2001
Institute Committee Review: Jun-Jul Oct-Nov Feb-Mar
Earliest Funding: Sep 2001 Jan 2002 May 2002
Only one Small Grant application may be submitted by a Principal
Investigator per receipt date in response to this program announcement.
REVIEW CONSIDERATIONS
Upon receipt, applications will be reviewed for completeness by CSR.
Applications for this PA must focus on one of the 24 topics identified.
Incomplete applications will be returned to the applicant without
further consideration. Applications that are complete will be
evaluated for scientific and technical merit by an appropriate peer
review group convened by the NIA in accordance with the review criteria
stated below. As part of the initial merit review, all applications
will receive a written critique and may undergo a process in which only
those applications deemed to have the highest scientific merit,
generally the top half of applications under review, will be discussed,
and assigned a priority score.
Review Criteria
The goals of NIH-supported research are to advance our understanding of
biological systems, improve the control of disease, and enhance health.
In the written review, comments on the following aspects of the
application will be made in order to judge the likelihood that the
proposed research will have a substantial impact on the pursuit of
these goals. Each of these criteria will be addressed and considered by
the reviewers in assigning the overall score weighting them as
appropriate for each application. Note that the application does not
need to be strong in all categories to be judged likely to have a major
scientific impact and thus deserve a high priority score. For example,
an investigator may propose to carry out important work that by its
nature is not innovative but is essential to move a field forward.
1. Significance. Does this study address an important problem? If the
aims of the application are achieved, how will scientific knowledge be
advanced? What will be the effect of these studies on the concepts or
methods that drive this field?
2. Approach. Are the conceptual framework, design, methods, and
analyses adequately developed, well-integrated, and appropriate to the
aims of a pilot project? Does the applicant acknowledge potential
problem areas and consider alternative tactics?
3. Innovation. Does the project employ novel concepts, approaches or
method? Are the aims original and innovative? Does the project
challenge existing paradigms or develop new methodologies or
technologies?
4. Investigator. Is the investigator appropriately trained and well
suited to carry out this work? Is the work proposed appropriate to the
experience level of the principal investigator and other researchers
(if any)?
5. Environment. Does the scientific environment in which the work
will be done contribute to the probability of success? Do the proposed
experiments take advantage of unique features of the scientific
environment or employ useful collaborative arrangements? Is there
evidence of institutional support?
The initial review group will also examine: the likelihood that the
pilot project will lead to the development of an R01 application, or
significant advancement of aging research, the appropriateness of
proposed project budget and duration, the adequacy of plans to include
both genders and minorities and their subgroups as appropriate for the
scientific goals of the research and plans for the recruitment and
retention of subjects, the provisions for the protection of human and
animal subjects, and the safety of the research
environment.
AWARD CRITERIA
Applications will compete for available funds with all other approved
applications. The following will be considered in making funding
decisions:
o quality of the proposed project as determined by peer review
o availability of funds
o program priority
INQUIRIES
Inquiries are encouraged. The opportunity to clarify any issues or
questions from potential applicants is welcome.
For applications with primary emphasis on the biology of aging contact:
Dr. David B. Finkelstein
Biology of Aging Program
National Institute on Aging
7201 Wisconsin Avenue, Suite 2C231, MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 496-6402
FAX: (301) 402-0010
Email: BAPquery@exmur.nia.nih.gov
For applications with primary emphasis on behavioral or social research
on aging contact:
Ms. Angie Chon-Lee
Behavioral and Social Research Program
National Institute on Aging
7201 Wisconsin Avenue, Suite 5C533, MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 594-5943
FAX: (301) 402-0051
Email: BSRquery@exmur.nia.nih.gov
For applications with primary emphasis on the neuroscience or
neuropsychology of aging contact:
Dr. Judy Finkelstein
Neuroscience and Neuropsychology of Aging Program
National Institute on Aging
7201 Wisconsin Avenue, Suite 3C307, MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 496-9350
FAX: (301) 496-1494
Email: NNAquery@exmur.nia.nih.gov
For applications with primary emphasis on geriatrics research contact:
Ms. Wanda Solomon
Geriatrics Program
National Institute on Aging
7201 Wisconsin Avenue, Suite 3E327 MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 435-3046
FAX: (301) 402-1784
Email: GPquery@exmur.nia.nih.gov
Direct inquiries regarding fiscal matters to:
Ms. Linda Whipp
Grants and Contracts Management Office
National Institute on Aging
7201 Wisconsin Avenue, Suite 2N212, MSC 9205
Bethesda, MD 20892
Telephone: (301) 496-1472
FAX: (301) 402-3672
Email: WhippL@exmur.nia.nih.gov
AUTHORITY AND REGULATIONS
This program is described in the Catalog of Federal Domestic Assistance
No. 93.866. Awards are made under authorization of sections 301 and 405
of the Public Health Service Act as amended (42 USC 241 and 284) and
administered under NIH grants policies and Federal Regulations 42 CFR
52 and 45 CFR Parts 74 and 92. This program is not subject to the
intergovernmental review requirements of Executive Order 12372 or
Health Systems Agency review.
The PHS strongly encourages all grant and contract recipients to
provide a smoke-free workplace and promote the non-use of all tobacco
products. In addition, Public Law 103-227, the Pro-Children Act of
1994, prohibits smoking in certain facilities (or in some cases, any
portion of a facility) in which regular or routine education, library,
day care, health care or early childhood development services are
provided to children. This is consistent with the PHS mission to
protect and advance the physical and mental health of the American
people.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|